Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mrna degradation

Journal of Experimental Medicine

Volumn 177, Issue 6, 1993, Pages 1675-1680

  Moreira, Andre L ^a   Sampaio, Elizabeth P ^a,c   Zmuidzinas, Antonina ^b   Frindt, Paula ^a   Smith, Kendall A ^b   Kaplan, Gilla ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; RACEMIC MIXTURE; RNA DEGRADATION; TUBERCULOSIS;

ANIMAL; CELLS, CULTURED; DEXAMETHASONE; HUMAN; MONOCYTES; PENTOXIFYLLINE; RNA, MESSENGER; SHEEP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THALIDOMIDE; TUMOR NECROSIS FACTOR;

EID: 0027230553     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.6.1675     Document Type: Article

References (19)

1. Samo, E.N., G.E. Grau, L.M.M. Vieira, and A.C. Nery. 1991. Seram levels of TNF-a and IL-1β during leprosy reactional states. Clin. Exp Immunol. 84:103.
2. Sampaio, E.P., A.L. Moreira, E.N. Sarno, A.M. Malta, and G. Kaplan. 1992. Prolonged treatment with recombinant interferon 7 induces erythema nodosum leprosum in leproma-tous leprosy patients. J. Exp Med. 175:1729.
3. Sampaio, E.P., E.N. Sarno, R. Galilly, Z.A. Cohn, and G. Kaplan. 1991. Thalidomide selectively inhibits tumor necrosis factor a production by stimulated human monocytes. J. Exp Med. 173:699.
4. Doherty, G.M., J.C. Jensen, H.R. Alexander, C.M. Buresh, and J.A. Norton. 1991. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery (St. Louis). 110:192.
5. Han, J., P. Thompson, and B. Beutler. 1990. Dexamethasone and pentoxifylline inhibit endotoxin induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.J Exp Med. 172:391.
6. Gunning, P., Ponte, H. Okayama, J. Engles, H. Blau, and L. Kedes. 1983. Isolation and characterization of full-length cDNA clones for human α-β and 7- actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cystein that is subsequently removed. Mol. Cell. Biol. 3:787.
7. Beutler, B., and A. Cerami. 1988. The common mediator of shock, cachexia, and tumor necrosis. Adv. Immunol. 42:213.
8. Sen, R., and D. Baltimore. 1986. Inducibility of k immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism. Cell. 47:921.
9. Sariban, E., K. Imamura, R. Luelbers, and D. Kufe. 1988. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest. 81:1506.
10. Zuckerman, S.H., G.F. Evans, and L. Guthrie. 1991. transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology 73:460.
11. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp Med. 171:465.
12. Sung, S.S., and J.A. Walters. 1991. Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J. Clin. Invest. 88:1915.
13. Thorens, B., J.J. Mermod, and P. Vassali. 1987. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell. 48:671.
14. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:659.
15. Beulter, B., N. Krochin, I.W. Mitsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science (Wash. DC). 232:977.
16. Han, J., G. Huez, and B. Beutler. 1990. Interactive effects of the tumor necrosis factor promoter and 3'-untranslated region. J. Immunol. 146:1843.
17. Lindstein, T., C.H. June, J.A. Ledbetter, G. Stella, and C.B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (Wash. DC). 244:339.
18. Fong, Y., K.J. Tracey, and L.L. Maldawer et al. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J Exp Med. 170:1627.
19. Blaschke, G. 1986. Chromatographic resolution of chiral drags on polyamides and cellulose triacetate.J. Liq. Chromatogr. 9:341.